Journal: International Journal of Molecular Sciences
Article Title: Functional Expression of Piezo1 in Dorsal Root Ganglion (DRG) Neurons
doi: 10.3390/ijms21113834
Figure Lengend Snippet: Inhibition of Piezo1 by mechanical-ion channel inhibitors and short hairpin RNA-mediated silencing of Piezo1. ( A ) The Yoda1 (10 μM, 10 s)-induced intracellular Ca 2+ increase. The Yoda1 (10 μM, 10 s)-induced intracellular Ca 2+ increase is reversibly inhibited by ruthenium red (30 μM, N and P-type nonselective Ca 2+ channel blocker, red) ( B ), GsMTx4 (2.5 μM, selective stretch-activated channel blocker, blue) ( C ), and Dooku1 (10 μM, Yoda1 analogue, green) ( D ). The arrows indicate spontaneous intracellular Ca 2+ increase. ( E ) The bars indicate treatment with various inhibitors: ruthenium red (RR) (control, n = 6; RR, n = 12, two-way ANOVA (Fisher’s LSD test), *, p < 0.05); GsMTx4 (control, n = 23; Gs, n = 22, two-way ANOVA (Fisher’s LSD test), ***, p < 0.001); and Dooku1 (control, n = 9; Dk, n = 19, two-way ANOVA (Fisher’s LSD test), *, p < 0.05). ( F ) piezo1 mRNA levels, normalized by gapdh, were quantified by a TaqMan assay after transfection with sh-piezo1 dorsal root ganglion (DRG) neurons (unpaired t-test, **** p < 0.0001). ( G ) Application of Yoda1 (10 μM, 10 s)-induced Ca 2+ response in mouse DRG neurons transfected with sh-piezo1 (red) and scramble (gray) or control (black). ( H ) Mean normalized amplitude of Yoda1-induced Ca 2+ response (control, n = 29; scramble, n = 22; sh-piezo1, n = 18, one-way ANOVA (Dunn’s multiple comparisons test, ns; nonsignificant, **, p < 0.01). High potassium chloride (50 mM) is a neuronal marker. All results are presented as the mean ± standard error of the mean (SEM) (control versus sh-piezo1 and scramble or control versus each drug). DRG: dorsal root ganglion; sh: short hairpin.
Article Snippet: After transferring to a polyvinylidene fluoride (PVDF) membrane, the blots were incubated overnight at 4 °C with a rabbit polyclonal antibody against Piezo1 (1:500, Proteintech) and a mouse monoclonal antibody against β-actin (1:1000, Sigma).
Techniques: Inhibition, shRNA, Control, TaqMan Assay, Transfection, Marker